Candel Therapeutics, Inc. CADL Initial Fair Value Of Warrant Liability In Connection With Debt Financing

Initial Fair Value Of Warrant Liability In Connection With Debt Financing at other companies

Intuitive Machines, Inc.LUNR

$69.82M+171%

Archer AviationACHR

$7.1M-85.1%

Bakkt BKKT

$12.03M-18.0%

KEE

Keel Infrastructure Corp. Common StockKEEL

$2.15M—

SLD

Solid PowerSLDP

$4.24M+48.5%

Aclaris TherapeuticsACRS

$11.21M—

Other financials

Income statement

See full

Revenue$31.0K0.0%

Operating income-$16.3M-100%

Net income-$8.9M-220%

EPS (diluted)-$0.14-208%

Balance sheet

See full

Cash & equivalents$194.8M+111%

Total debt$2.8M-73.9%

Total equity$138.0M+84.8%

Total assets$201.9M+111%

Cash flow

See full

Operating cash flow-$18.0M-109%

CapEx$675.0K+22,400%

Free cash flow-$18.7M-117%

Valuation

See full

Market cap$693.87M+192%

Enterprise value$501.88M+220%

P/S5,595.7×-18,674×

Profitability

See full

Operating margin-28,000.8%+15,050pp

Net margin-15,156.5%-5,064pp

FCF margin-26,383.9%+14,851pp

Returns & leverage

See full

Return on equity-51.2%-16.6pp

Debt / equity0×-0.1×

Current ratio28×+23.4×

Where this comes from

Reported directly by Candel Therapeutics, Inc. in its filing.

Tagged under the XBRL concept cadl:InitialFairValueOfWarrantLiabilityInConnectionWithDebtFinancing.

The official record: Candel Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Candel Therapeutics, Inc.'s initial fair value of warrant liability in connection with debt financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Candel Therapeutics, Inc.'s initial fair value of warrant liability in connection with debt financing?: Candel Therapeutics, Inc. (CADL) reported initial fair value of warrant liability in connection with debt financing of $519.75K in Q4 2025.
What does initial fair value of warrant liability in connection with debt financing mean?: This captures the initial valuation of warrant liabilities recognized at the inception of a debt financing arrangement. It provides insight into the total cost of capital and the potential future dilution associated with equity-linked financing instruments.